Skip to main content
. 2008 Jul-Aug;2(4 Suppl 2):S47–S53.

Figure 2.

Figure 2.

Kaplan-Meier estimates of (A) time to progression and (B) overall survival among chemotherapy-naive advanced gastric cancer patients treated with docetaxel, cisplatin, and fluorouracil (DCF) or cisplatin and fluorouracil (CF; full analysis population). From Van Cutsem et al.19 Reprinted with permission from the American Society of Clinical Oncology.